Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells

The phosphatidylinositol 3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling pathway is a therapeutic target for various types of human tumors, and dual PI3K/mTOR inhibitors demonstrate antitumor activities in both preclinical and clinical studies. However, resistance mechanisms limit their...

Descripción completa

Detalles Bibliográficos
Autores principales: Murase, Yusuke, Hosoya, Kenji, Sato, Takachika, Kim, Sangho, Okumura, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848474/
https://www.ncbi.nlm.nih.gov/pubmed/35088890
http://dx.doi.org/10.3892/or.2022.8272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848474/
https://www.ncbi.nlm.nih.gov/pubmed/35088890
http://dx.doi.org/10.3892/or.2022.8272

Ejemplares similares